Houston Neurocare, P.a.

Houston, TX Doing business as (Aff: ST Lukes Escpl Hos IND Pra)

UEI
FWAHKYLAL953
CAGE
7Z9F3
Primary NAICS
621111 Offices of Physicians (except Mental Health Specialists)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6624 Fannin St #1670, Houston, TX 77030, USA
Founded
1989
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
University Of California Irvine Title: “Influence of NT5c1A antibodies on disease progression, clinical phenotype and blood and muscle biomarkers in sporadic Inclusion Body Myositis… R01AR078340 $7,524

Similar vendors

Vendor Location Primary NAICS
(Aff: Saint Johns Health Center) UEI RG2GTSYTHE73 Santa Monica, CA 621399 Offices of All Other Miscellaneous Health Practitioners
A L S Therapy Development Institute UEI C6KRH86RM6E6 Watertown, MA —
Presbyterian / ST. Luke's Medical Center UEI MK25DF5EMKS7 Denver, CO —
Uhp-Vumc UEI XBBGHBC3KM87 Amsterdam, NH 622110 General Medical and Surgical Hospitals
Financial Affairs UEI R115JBLDX229 Chicago, IL —

About the company

Houston Neurocare, P.A., doing business as an affiliate of St. Luke's Episcopal Hospital Independent Practice Association, is a for-profit subchapter S corporation providing healthcare services. Through federal grants, Houston Neurocare has conducted medical research related to sporadic inclusion body myositis (SIBM) and amyotrophic lateral sclerosis (ALS).

As a subrecipient, Houston Neurocare participated in a study of SIBM patients led by the University of California, Irvine. The research analyzed disease progression, clinical phenotype, blood, and muscle biomarkers in SIBM patients over two years. Houston Neurocare also took part in an ALS study led by the University of Kansas Medical Center Research Institute. That research focused on testing a potential ALS therapy. Houston Neurocare's role included recruiting, screening, enrolling, and monitoring subjects as well as reporting data. The SIBM study was funded by an unnamed federal grant program, while the ALS study was supported by an FDA grant.

Quick answers

Is Houston Neurocare, P.a. registered in SAM.gov?

Yes. Houston Neurocare, P.a.'s SAM.gov registration is active through May 5, 2027.

On GovTribe

See Houston Neurocare, P.a.'s full federal record

  • Similar vendors